logo
Plus   Neg
Share
Email

FDA Approves Regeneron's EYLEA Injection Prefilled Syringe - Quick Facts

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the Chemistry, Manufacturing and Controls (CMC) Prior-Approval Supplement (PAS) for the EYLEA (aflibercept) Injection prefilled syringe.

The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer EYLEA that requires fewer preparation steps compared to vials. Market supply of the EYLEA prefilled syringe is expected to be available to physicians and patients this year.

EYLEA is the only anti- vascular endothelial growth factor (VEGF) approved to treat four retinal conditions with a single dose strength prefilled syringe. It is available in multiple dosing intervals, offering doctors flexibility to address patients' individual needs.

The sterilized prefilled syringe offers the same medicine as the currently available EYLEA, in an easier to use and administer presentation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google announced a batch of renewable energy deals totaling 1.6 GW through 18 acquisitions spread across three continents. The deals are intended to "spur the construction of more than $2 billion in new energy infrastructure," the company said. Google said the deals will increase its worldwide portfolio... Beyond Meat's main competitor Impossible Foods will launch its grocery store in California on Friday. Beyond Meat Inc. (BYND), the meatless burger and sausage maker, announced the appointment of Sanjay Shah as Chief Operating Officer. Shah will assume the responsibility for Beyond Meat's global operations and production, effective September 18.
Follow RTT
>